Regenicin, Inc. (RGIN)

Regenicin Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Cash & Equivalents	10.88	0.01	0	0	0	0
Short-Term Investments	0.98	0	0	0	0	0.01
Cash & Short-Term Investments	11.86	0.02	0	0	0.01	0.01
Cash Growth	321461.66%	236.17%	11.30%	-22.09%	-52.34%	-59.00%
Prepaid Expenses	-	-	-	-	-	0.05
Total Current Assets	11.86	0.02	0	0	0.01	0.06
Other Long-Term Assets	-	-0	-	-	-	-
Total Assets	11.86	0.02	0	0	0.01	0.06
Accounts Payable	-	0.1	0.09	0.09	0.14	0.07
Accrued Expenses	4.89	4.87	4.27	3.62	3.14	2.63
Short-Term Debt	0.64	0.64	0.6	0.58	0.45	0.36
Total Current Liabilities	18.07	5.61	4.96	4.29	3.73	3.06
Total Liabilities	18.07	5.61	4.96	4.29	3.73	3.06
Common Stock	0.16	0.16	0.16	0.16	0.16	0.16
Additional Paid-In Capital	10.21	10.21	10.21	10.21	10.21	10.18
Retained Earnings	-16.57	-15.96	-15.32	-14.65	-14.09	-13.33
Treasury Stock	-0	-0	-0	-0	-0	-0
Comprehensive Income & Other	-	-	-	-	-	0
Total Common Equity	-6.21	-5.6	-4.96	-4.29	-3.73	-3
Shareholders' Equity	-6.21	-5.6	-4.96	-4.29	-3.73	-3
Total Liabilities & Equity	11.86	0.02	0	0	0.01	0.06
Total Debt	0.64	0.64	0.6	0.58	0.45	0.36
Net Cash (Debt)	11.22	-0.63	-0.6	-0.57	-0.45	-0.35
Net Cash Per Share	0.07	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	153.48	153.48	153.48	153.48	153.48	153.48
Total Common Shares Outstanding	153.48	153.48	153.48	153.48	153.48	153.48
Working Capital	-6.21	-5.6	-4.96	-4.29	-3.73	-3
Book Value Per Share	-0.04	-0.04	-0.03	-0.03	-0.02	-0.02
Tangible Book Value	-6.21	-5.6	-4.96	-4.29	-3.73	-3
Tangible Book Value Per Share	-0.04	-0.04	-0.03	-0.03	-0.02	-0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.